Early research (Phase 1)Ended earlyNCT02848248What this trial is testingA Safety Study of SGN-CD123A in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Seagen Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00049504What this trial is testingHaploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+94 more Fred Hutchinson Cancer Center 53
Early research (Phase 1)Ended earlyNCT01904643What this trial is testingLenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more Stanford University 17
Testing effectiveness (Phase 2)Study completedNCT01349049What this trial is testingPhase 1/2 Safety and Efficacy of PLX3397 in Adults With Relapsed or Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Daiichi Sankyo 90
Early research (Phase 1)Ended earlyNCT02412475What this trial is testingEpigenetic Reprogramming in Relapse AMLWho this might be right forLeukemia, Acute Myeloid Michael Burke 3
Not applicableLooking for participantsNCT01137643What this trial is testingTissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more UNC Lineberger Comprehensive Cancer Center 15,000
Early research (Phase 1)Study completedNCT03441555What this trial is testingVenetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML) AbbVie 36
Testing effectiveness (Phase 2)Study completedNCT02544438What this trial is testingStudy Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia BioSight Ltd. 20
Not applicableEnded earlyNCT01077440What this trial is testingPresence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell TransplantWho this might be right forCancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more Vanderbilt University 24
Testing effectiveness (Phase 2)Study completedNCT00707408What this trial is testingHigh-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML)Who this might be right forAML Nantes University Hospital 15
Testing effectiveness (Phase 2)Ended earlyNCT05886491What this trial is testingGDX012 in Adults With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forLeukemia Takeda 16
Early research (Phase 1)Study completedNCT00509691What this trial is testingVaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyWho this might be right forCancer University of Louisville 20
Early research (Phase 1)WithdrawnNCT05248685What this trial is testingOptimized Dual CD33/CLL1 CAR T Cells in Subjects With Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Beijing Boren Hospital
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06987058What this trial is testingRVU120 Rollover StudyWho this might be right forAdvanced Solid TumorsAcute Myeloid Leukaemia (AML)High-risk Myelodysplastic Syndrome Ryvu Therapeutics SA 14
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT02306291What this trial is testingStudy to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AMLWho this might be right forLeukemia, Myeloid, Acute GlycoMimetics Incorporated 91
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT05518357What this trial is testingLILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia Hebei Yanda Ludaopei Hospital 2
Early research (Phase 1)Study completedNCT01246622What this trial is testingLenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+4 more Roswell Park Cancer Institute 32
Early research (Phase 1)Study completedNCT03125239What this trial is testingCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed Adult Acute Myeloid LeukemiaRefractory Adult Acute Myeloid Leukemia Jacqueline Garcia, MD 16